Vice President, Clinical Development-Ophthalmology
Annexon Biosciences
About this role
A Vice President, Clinical Development-Ophthalmology at Annexon Biosciences leads the clinical strategy for ophthalmology programs, including vonaprument, driving development, regulatory submissions, and commercialization while collaborating across teams and engaging with key opinion leaders.
Skills
Qualifications
About Annexon Biosciences
annexonbio.comAnnexon Biosciences is a biopharmaceutical company developing next‑generation complement therapies by targeting C1q, the initiating molecule of the classical complement pathway. By blocking C1q, Annexon aims to prevent downstream immune‑mediated damage in autoimmune, neurodegenerative (including Alzheimer’s and Huntington’s) and ophthalmic diseases affecting the body, brain, and eye. The company advances C1q‑targeted biologics through a pipeline of therapeutic candidates intended to provide disease‑modifying treatments for conditions driven by classical complement activation.
Recent company news
GlobeNewswireAnnexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference
3 weeks ago
TipRanksAnnexon Biosciences Announces Planned Retirement of Board Chairman
4 weeks ago
Stock TitanAnnexon targeting neuroinflammatory disease, CEO to speak at TD Cowen
3 weeks ago
Investing.comAnnexon Biosciences stock rating reiterated by Cantor Fitzgerald
Jan 14, 2026
Yahoo FinanceAnnexon Announces Completion of Enrollment in Pivotal Phase 3 ARCHER II Trial of Vonaprument (formerly ANX007) for Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy
Jul 24, 2025
About Annexon Biosciences
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Annexon Biosciences.
Salary
$400k – $428k
per year
More jobs at Annexon Biosciences
Similar Jobs
Vice President, Clinical Development (Rare Metabolic Disease)
Travere Therapeutics
Vice President, Gastrointestinal and Established Brands
Ferring
Vice President, Clinical Development
Alkeus Pharmaceuticals
Vice President, Biometrics
altimmune
Vice President Product Strategy & Commercialization
Holistic Industries
Vice President, Clinical Development (Oncology)
allogene